Linking proteins directly to nucleic acids has been a complex task. By hybridizing a bifunctional peptide nucleic acid (PNA) consisting of a nucleic acid binding moiety and a nuclear localization signal (NLS) we have previously demonstrated that it is possible to link protein functions directly to nucleic acids containing a PNA target site. By hybridizing fluorKeywords: PNA; NLS; in vivo; transfection; gene therapy Nuclear entry has been a hurdle to overcome in transfection assays and in gene therapy protocols based on transfection. We have used the properties of PNA 1 in combination with the SV40 NLS 2 to create a hybrid PNA-NLS peptide.
Nuclear entry has been a hurdle to overcome in transfection assays and in gene therapy protocols based on transfection. We have used the properties of PNA 1 in combination with the SV40 NLS 2 to create a hybrid PNA-NLS peptide. 3 By introducing a target site in the nucleic acid to be transfected it is possible to hybridize the PNA-NLS peptide to its cognate sequence thus creating a complex, bioplex, (biological complexing), with an NLS function. In the majority of experiments in this study we have not used pure bioplexes, but instead polyplexes mixing PNA-NLS and oligonucleotides with the standard transfection reagent polyethyleneimine (PEI). We have previously demonstrated the feasibility of this technology under in vitro conditions. 4 In the present study we have investigated the possibility of using bifunctional PNA-NLS peptides to enhance nuclear uptake in vivo, as well as using the PNA-NLS molecule as the active transfection reagent. In all experiments two sets of oligonucleotides were used. The fluorophore Cy-3 5 was coupled to an oligonucleotide which was antisense to the PNA sequence, whereas the Cy-5 fluorophore was coupled to the corresponding sense oligonucleotide, serving as an internal control.
In a first set of experiments we investigated the effect of intradermal/subcutaneous transfection. Following intradermal/subcutaneous injection in mouse tail of the PNA-NLS/Cy-3 complex and Cy-5 control oligonucleotide a pronounced nuclear translocation of the Cy-3 oligonucleotide could be detected (Figure 1 ). In the granular cell layer an unspecific uptake of oligonucleotides can be seen as compared with the spinous cell layer. This can possibly be due to the stratification process of the skin. However, the nuclear uptake is more pronounced for the PNA-NLS/Cy-3 oligonucleotide in both the granular and spinous cell layer. For the spinous cell layer, indicated with a white line, only the PNA-NLS/Cy-3 oligonucleotide shows a significant presence in the nuclei as can be seen when comparing panel c and d/e. In panel a, the spinous cell layer show a pink coloration due to the presence of the PNA-NLS/Cy-3 oligonucleotide and simultaneous DAPI staining of DNA in the nucleus. To show the nuclear exclusion of non-targeted Cy-5 oligonucleotide, the image in panel e is enhanced. In this panel the green fluorescence in the cytoplasm is clearly visible, whereas nuclei are excluded. The intradermal/ subcutaneous transfection shows a clear nuclear translocation of the PNA-NLS/Cy-3 oligonucleotide whereas the internal Cy-5 control was not present at significant levels in the nuclei of Cy-3 positive cells. The densely nucleated area in the tissue section is devoid of either oligonucleotide, thus indicating that no detectable penetration of the transfection complexes has occurred in this region. In total more than 300 nuclei were found to be predominantly positive for Cy-3 fluorescence. We could not detect any nuclei which were predominantly positive for Cy-5. To illustrate the nuclear accumulation of the PNA-NLS/Cy-3 oligonucleotide as compared with the Cy-5 oligonucleotide we measured the fluorescence along the indicated white line in Figure 1 , panels a-e. The arrows indicate representative nuclei both in the panels and in the histogram.
In a next set of experiments we investigated the effect of bifunctional peptides in intramuscular injections of oligonucleotides. As can be seen in Figure 2 , panel c there is a pronounced fluorescence in the perinuclear/nuclear region derived from the PNA-NLS/Cy-3 oligonucleotide.
Subsequently, we studied injections into the liver. The liver is a more difficult organ to analyze due to the background fluorescence in the Cy-3 spectrum. Even though the background in the Cy-3 emission spectra is high in this organ it is possible to separate the fluorescence derived from the PNA-NLS/Cy-3 oligonucleotide. In Figure 3b we can see that a number of nuclei immediately surrounding the injection point of the liver are positive for the PNA-NLS/Cy-3 oligonucleotide. Distal from the point of injection, the number of positive nuclei decreases as well as the cells which are positive for the Cy-5 labeled oligonucleotide.
When comparing the transfection efficacy of different combinations of oligonucleotides, PEI 6 and PNA-NLS, some of the differences are notable. Transfection with oligonucleotides alone gave poor cellular uptake compared with transfection of oligonucleotides condensed with PEI or oligonucleotides hybridized with PNA-NLS. PEI condensed oligonucleotides, polyplex, can be detected inside the cells as large complexes with a non-homogeneous cellular distribution. Oligonucleotides hybridized with PNA-NLS, in the absence of PEI, bioplex, condense into complexes that also are taken up by cells efficiently. These complexes are dispersed intracellularly in a less aggregated way than the polyplexes and translocate more efficiently to the nuclei (Figure 4) . In Figure 4 , panel a and c, transfection has been made with PEI or with pure bioplex respectively. Panel b shows a section of muscle transfected with bioplex. Panel d is a nucleus from a myofiber at high magnification. The intranuclear distribution of fluorescently labeled oligonucleotide is very similar to the intranuclear distribution in Figure 2 . The overall amount of fluorescence does not differ from PEItransfected cells as compared with bioplex-transfected cells. Thus, this demonstrates that bioplexes themselves can enter cells efficiently and may also disperse more easily once inside the cells. The data from our bioplex experiments indicate that transfection by bioplex alone could be as efficient as polyplex transfection.
Moreover, our data suggest that the physical properties of the NLS signal are the cause of the efficient transfection of the bioplex. When using a PNA molecule alone lacking the NLS portion no detectable transfection took place (unpublished data). The same is true when adding extended PNA molecules lacking NLS signals. The effect of the NLS portion is therefore likely to be two-fold: first it affects the physical properties of the hybridized PNA-NLS/Cy-3 oligonucleotide enabling intracellular uptake and second, once internalized, it provides a specific signal for nuclear translocation. Our in vivo findings demonstrate that a PNA molecule conjugated to an SV40 NLS peptide can work as a nuclear targeting signal when hybridized to a fluorescently labeled oligonucleotide. The NLS-mediated nuclear translocation of nucleic acids was observed in all cell types tested. The differences between cell types may mainly be related to their ability to take up the transfection complexes. This issue is being addressed presently by linking cellular receptor ligands 7 to the nucleic acid via a PNA adaptor. Furthermore, the levels of karyopherins/importins could vary between different tissues. 8, 9 The potential influence of such a variability on nuclear translocation efficacy could be overcome by linking multiple types of NLS signals to the plasmid. The variation of NLS receptor species in different tissues might also be exploited to achieve a higher degree of selectivity in transfection of targeted organs potentially in combination with tissue-specific promotors. In the intramuscular injection, the oligonucleotide appears to be located to the perinuclear area, as well as to the nucleus. This could reflect that different levels of nuclear import proteins may be present in various tissues. As has been reported, the different NLS receptor subunits (␣/␤) are expressed at varying levels in the tissue of mice whereas the ␤-subunit is maintained at relatively constant levels. It is hypothesized that the ␣-subunit is regulating the nuclear transport of proteins containing NLS signals of different types. In our experiments we have established the feasibility of an active in vivo targeting of nucleic acid complexes to the nuclei of cells in vivo. This platform technology is of potential value for transfections in general and may also be applied in the context of gene therapy. 10 
